Towards Healthcare
Cell and Gene Therapy Market
Updated Date: 19 January 2026   |   Report Code: 5052
sales@towardshealthcare.com +1 804-441-9344
Download Sample Order Now

Cell and Gene Therapy Market Size to Hit US$ 232.22 Billion by 2035

Forecasts suggest that the cell and gene therapy market will expand USD 232.22 billion by 2035, with a CAGR of 24% during the forecasted period. Gene therapy is rapidly evolving, driven by CRISPR and CAR-T advancements. Once focused on rare diseases and cancer, it now targets neurological, cardiovascular, and autoimmune conditions. With fast-tracked approvals, major investments, and growing clinical trials, the future of gene therapy looks highly promising.

Last Updated : 19 January 2026 Category: Biotechnology Insight Code: 5052 Format: PDF / PPT / Excel

Content

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Cell and Gene Therapy Market Assessment

  • Overview
  • Global Cell and Gene Therapy Market Size Value (US$) and Volume (Billion Tons), by Therapy Type (2021 – 2033)
    • Cell Therapy
      • Stem Cells
      • T Cells
      • Dendritic Cells
      • NK Cells
      • Tumor Cells
    • Gene Therapy
  • Global Cell and Gene Therapy Market Size Value (US$) and Volume (Billion Tons), by Therapeutic Class (2021 – 2033)
    • Cardiovascular Disease
    • Cancer
    • Genetic Disorder
    • Rare Diseases
    • Oncology
    • Hematology
    • Ophthalmology
    • Infectious Disease
    • Neurological Disorders
  • Global Cell and Gene Therapy Market Size Value (US$) and Volume (Billion Tons), by Delivery Method (2021 – 2033)
    • In Vivo
    • Ex vivo
  • Global Cell and Gene Therapy Market Size Value (US$) and Volume (Billion Tons), by End-Users (2021 – 2033)
    • Hospitals
    • Cancer Care Centers
    • Wound Care Centers
    • Others
  • Global Cell and Gene Therapy Market Size Value (US$) and Volume (Billion Tons), by Region (2021 – 2033)
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • MEA

North America Cell and Gene Therapy Market Assessment

  • Overview
  • North America Cell and Gene Therapy Market Size Value (US$) and Volume (Billion Tons), by Therapy Type (2021 – 2033)
    • Cell Therapy
      • Stem Cells
      • T Cells
      • Dendritic Cells
      • NK Cells
      • Tumor Cells
    • Gene Therapy
  • North America Cell and Gene Therapy Market Size Value (US$) and Volume (Billion Tons), by Therapeutic Class (2021 – 2033)
    • Cardiovascular Disease
    • Cancer
    • Genetic Disorder
    • Rare Diseases
    • Oncology
    • Hematology
    • Ophthalmology
    • Infectious Disease
    • Neurological Disorders
  • North America Cell and Gene Therapy Market Size Value (US$) and Volume (Billion Tons), by Delivery Method (2021 – 2033)
    • In Vivo
    • Ex vivo
  • North America Cell and Gene Therapy Market Size Value (US$) and Volume (Billion Tons), by End-Users (2021 – 2033)
    • Hospitals
    • Cancer Care Centers
    • Wound Care Centers
    • Others

Europe Cell and Gene Therapy Market Assessment

  • Overview
  • Europe Cell and Gene Therapy Market Size Value (US$) and Volume (Billion Tons), by Therapy Type (2021 – 2033)
    • Cell Therapy
      • Stem Cells
      • T Cells
      • Dendritic Cells
      • NK Cells
      • Tumor Cells
    • Gene Therapy
  • Europe Cell and Gene Therapy Market Size Value (US$) and Volume (Billion Tons), by Therapeutic Class (2021 – 2033)
    • Cardiovascular Disease
    • Cancer
    • Genetic Disorder
    • Rare Diseases
    • Oncology
    • Hematology
    • Ophthalmology
    • Infectious Disease
    • Neurological Disorders
  • Europe Cell and Gene Therapy Market Size Value (US$) and Volume (Billion Tons), by Delivery Method (2021 – 2033)
    • In Vivo
    • Ex vivo
  • Europe Cell and Gene Therapy Market Size Value (US$) and Volume (Billion Tons), by End-Users (2021 – 2033)
    • Hospitals
    • Cancer Care Centers
    • Wound Care Centers
    • Others

Asia Pacific Cell and Gene Therapy Market Assessment

  • Overview
  • Asia Pacific Cell and Gene Therapy Market Size Value (US$) and Volume (Billion Tons), by Therapy Type (2021 – 2033)
    • Cell Therapy
      • Stem Cells
      • T Cells
      • Dendritic Cells
      • NK Cells
      • Tumor Cells
    • Gene Therapy
  • Asia Pacific Cell and Gene Therapy Market Size Value (US$) and Volume (Billion Tons), by Therapeutic Class (2021 – 2033)
    • Cardiovascular Disease
    • Cancer
    • Genetic Disorder
    • Rare Diseases
    • Oncology
    • Hematology
    • Ophthalmology
    • Infectious Disease
    • Neurological Disorders
  • Asia Pacific Cell and Gene Therapy Market Size Value (US$) and Volume (Billion Tons), by Delivery Method (2021 – 2033)
    • In Vivo
    • Ex vivo
  • Asia Pacific Cell and Gene Therapy Market Size Value (US$) and Volume (Billion Tons), by End-Users (2021 – 2033)
    • Hospitals
    • Cancer Care Centers
    • Wound Care Centers
    • Others

Latin America Cell and Gene Therapy Market Assessment

  • Overview
  • Latin America Cell and Gene Therapy Market Size Value (US$) and Volume (Billion Tons), by Therapy Type (2021 – 2033)
    • Cell Therapy
      • Stem Cells
      • T Cells
      • Dendritic Cells
      • NK Cells
      • Tumor Cells
    • Gene Therapy
  • Latin America  Cell and Gene Therapy Market Size Value (US$) and Volume (Billion Tons), by Therapeutic Class (2021 – 2033)
    • Cardiovascular Disease
    • Cancer
    • Genetic Disorder
    • Rare Diseases
    • Oncology
    • Hematology
    • Ophthalmology
    • Infectious Disease
    • Neurological Disorders
  • Latin America Cell and Gene Therapy Market Size Value (US$) and Volume (Billion Tons), by Delivery Method (2021 – 2033)
    • In Vivo
    • Ex vivo
  • Latin America Cell and Gene Therapy Market Size Value (US$) and Volume (Billion Tons), by End-Users (2021 – 2033)
    • Hospitals
    • Cancer Care Centers
    • Wound Care Centers
    • Others

MEA Cell and Gene Therapy Market Assessment

  • Overview
  • MEA Cell and Gene Therapy Market Size Value (US$) and Volume (Billion Tons), by Therapy Type (2021 – 2033)
    • Cell Therapy
      • Stem Cells
      • T Cells
      • Dendritic Cells
      • NK Cells
      • Tumor Cells
    • Gene Therapy
  • MEA Cell and Gene Therapy Market Size Value (US$) and Volume (Billion Tons), by Therapeutic Class (2021 – 2033)
    • Cardiovascular Disease
    • Cancer
    • Genetic Disorder
    • Rare Diseases
    • Oncology
    • Hematology
    • Ophthalmology
    • Infectious Disease
    • Neurological Disorders
  • MEA Cell and Gene Therapy Market Size Value (US$) and Volume (Billion Tons), by Delivery Method (2021 – 2033)
    • In Vivo
    • Ex vivo
  • MEA Cell and Gene Therapy Market Size Value (US$) and Volume (Billion Tons), by End-Users (2021 – 2033)
    • Hospitals
    • Cancer Care Centers
    • Wound Care Centers
    • Others

Company Profiles

  • Alnylam Pharmaceuticals Inc.
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Amgen Inc.
  • Biogen Inc.
  • CORESTEM Inc.
  • Dendreon Pharmaceuticals LLC.
  • Helixmith Co. Ltd.
  • JCR Pharmaceuticals Co. Ltd.
  • Kolon TissueGene Inc.
  • Novartis AG
  • Pfizer Inc.

Conclusion & Recommendations

FAQ's

Answer : Cell and gene therapy from USD 27.02 billion in 2025 to over USD 232.22 billion by 2035, with 24% CAGR

Answer : North America spearheads innovation and market share, while Europe boosts growth through supportive regulations, and APAC rapidly scales with government backing and rising healthcare investment.

Answer : Rising approvals, expanding use beyond rare diseases, next-gen gene editing platforms, and strong demand for personalized medicine are transforming the field.
Any Questions

Meet the Team

Rohan Patil is a seasoned market research professional with over 5+ years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

Learn more about Rohan Patil

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar